165 related articles for article (PubMed ID: 24168512)
1. Pleomorphic lobular carcinoma of the breast: a morphologically and clinically distinct variant of lobular carcinoma.
Butler D; Rosa M
Arch Pathol Lab Med; 2013 Nov; 137(11):1688-92. PubMed ID: 24168512
[TBL] [Abstract][Full Text] [Related]
2. E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma.
Wahed A; Connelly J; Reese T
Ann Diagn Pathol; 2002 Dec; 6(6):349-51. PubMed ID: 12478484
[TBL] [Abstract][Full Text] [Related]
3. [Differential diagnosis of invasive ductal carcinoma versus invasive lobular carcinoma of breast].
Yin HF; Li T; Zhang H; Zhang S
Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):663-7. PubMed ID: 20078969
[TBL] [Abstract][Full Text] [Related]
4. Mixed pleomorphic lobular and apocrine carcinoma of the breast: A case report suggesting pathogenesis.
Ishii A; Oishi T; Kakuda Y; Yasui H; Kawata T; Muramatsu K; Takahashi K; Sugino T
Pathol Int; 2019 May; 69(5):288-293. PubMed ID: 30811750
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
[TBL] [Abstract][Full Text] [Related]
6. [Expression pattern of E-cadherin and p120-catenin in infiltrating lobular carcinoma and ductal carcinoma of the breast and its significance].
Li L; Bi XF; Xu X; Liu XY; Shen GH; Guo L; Yuan YL; Wang F; Wang MR; Yang HY
Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):273-7. PubMed ID: 20510078
[TBL] [Abstract][Full Text] [Related]
7. Fine-needle aspiration cytology of pleomorphic lobular carcinoma of the breast. Comparison with the classic type.
Auger M; Hüttner I
Cancer; 1997 Feb; 81(1):29-32. PubMed ID: 9100538
[TBL] [Abstract][Full Text] [Related]
8. Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast.
Palacios J; Sarrió D; García-Macias MC; Bryant B; Sobel ME; Merino MJ
Mod Pathol; 2003 Jul; 16(7):674-8. PubMed ID: 12861063
[TBL] [Abstract][Full Text] [Related]
9. Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity.
Reis-Filho JS; Simpson PT; Jones C; Steele D; Mackay A; Iravani M; Fenwick K; Valgeirsson H; Lambros M; Ashworth A; Palacios J; Schmitt F; Lakhani SR
J Pathol; 2005 Sep; 207(1):1-13. PubMed ID: 15957152
[TBL] [Abstract][Full Text] [Related]
10. Lobular carcinoma, not only a classic.
Brogi E; Murray MP; Corben AD
Breast J; 2010; 16 Suppl 1():S10-4. PubMed ID: 21050299
[TBL] [Abstract][Full Text] [Related]
11. Pleomorphic lobular carcinoma of the breast: molecular pathology and clinical impact.
Vargas AC; Lakhani SR; Simpson PT
Future Oncol; 2009 Mar; 5(2):233-43. PubMed ID: 19284381
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast.
Mastracci TL; Tjan S; Bane AL; O'Malley FP; Andrulis IL
Mod Pathol; 2005 Jun; 18(6):741-51. PubMed ID: 15696125
[TBL] [Abstract][Full Text] [Related]
13. [Expression of E-cadherin, p120catenin and 34βE12 in invasive lobular carcinoma of breast and their roles in diagnosis].
Yang GZ; Zhang XL; Li J; Ding HY
Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):741-4. PubMed ID: 22336156
[TBL] [Abstract][Full Text] [Related]
14. The clinical behavior of mixed ductal/lobular carcinoma of the breast: a clinicopathologic analysis.
Suryadevara A; Paruchuri LP; Banisaeed N; Dunnington G; Rao KA
World J Surg Oncol; 2010 Jun; 8():51. PubMed ID: 20565965
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR.
Radhi JM
Histopathology; 2000 Feb; 36(2):156-60. PubMed ID: 10672061
[TBL] [Abstract][Full Text] [Related]
16. The spectrum of morphomolecular abnormalities of the E-cadherin/catenin complex in pleomorphic lobular carcinoma of the breast.
Dabbs DJ; Kaplai M; Chivukula M; Kanbour A; Kanbour-Shakir A; Carter GJ
Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):260-6. PubMed ID: 17721269
[TBL] [Abstract][Full Text] [Related]
17. [Reappraisal of invasive lobular carcinoma].
Ding HY; Yang GZ
Zhonghua Bing Li Xue Za Zhi; 2009 Jun; 38(6):363-5. PubMed ID: 19781339
[No Abstract] [Full Text] [Related]
18. Clinical outcome in pleomorphic lobular carcinoma: a case-control study with comparison to classic invasive lobular carcinoma.
Narendra S; Jenkins SM; Khoor A; Nassar A
Ann Diagn Pathol; 2015 Apr; 19(2):64-9. PubMed ID: 25682191
[TBL] [Abstract][Full Text] [Related]
19. Pleomorphic lobular carcinoma of the breast with osteoclast-like giant cells: a case report and review of the literature.
Peña-Jaimes L; González-García I; Reguero-Callejas ME; Pinilla-Pagnon I; Pérez-Mies B; Albarrán-Artahona V; Martínez-Jañez N; Rosa-Rosa JM; Palacios J
Diagn Pathol; 2018 Aug; 13(1):62. PubMed ID: 30153845
[TBL] [Abstract][Full Text] [Related]
20. Expression of E-cadherin, alpha-catenin, and beta-catenin in tubulolobular carcinoma of the breast.
Kuroda H; Tamaru J; Takeuchi I; Ohnisi K; Sakamoto G; Adachi A; Kaneko K; Itoyama S
Virchows Arch; 2006 Apr; 448(4):500-5. PubMed ID: 16538444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
